Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 312

Kyn Therapeutics binds Celgene investment

UT Austin-founded Kyn Therapeutics has been backed by Celgene in a strategic pact that also includes a $80m non-equity payment, giving Celgene the right to license two programs.

Jan 18, 2019

Findologic discovers fresh capital

The seven-digit investment by BE Beteiligungen Fonds will help Salzburg e-commerce search spinout Findologic accelerate its international expansion and introduce new product features.

Jan 17, 2019

Daphne fertilises $4.9m

EPFL-founded exhaust filtering system spinout Daphne Technology has been backed by investors including oil producer Saudi Aramco.

Jan 17, 2019

Waterloo puts Velocity behind angel fund

University of Waterloo hopes to raise $1.2m to $1.8m for an angel fund to make equity investments in the winners of its Velocity Fund Finals competition.

Jan 17, 2019

UNLV touts Food Genes and Me

Dietary suggestion software spinout Food Genes and Me compiles personalised healthy eating tips based on uploaded DNA reports from external genetic analysis tools.

Jan 17, 2019

Purdue Ag-celerator seeds $100,000

Plant sciences startups Heliponix and Karyosoft each secured $50,000 investments after winning the fifth cohort of Purdue’s Ag-celerator competition.

Jan 16, 2019

Kerionics pumps in $228,000

Partly based on Polytechnic University of Valencia research, Kerionics hopes to commercialise a ceramic membrane-based system for producing industrial quantities of oxygen from waste gases.

Jan 16, 2019

Winningtemp calls Chalmers for $3.7m round

Chalmers Ventures has invested more funding in human resources app developer Winningtemp, which is preparing its employee wellbeing software for international expansion.

Jan 15, 2019

NYU and Futurx spark Glixogen’s genesis

New York University has teamed up with corporate-backed biopharmaceutical incubator Futurx to spawn neurodegenerative disease drug developer Glixogen Therapeutics.

Jan 15, 2019

Samsung trains its focus on Corephotonics

Samsung is reportedly eyeing Tel Aviv University-founded smartphone camera technology developer Corephotonics for $150m to $160m after backing its series B and C rounds.

Jan 15, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here